Broccoli, A.; Argnani, L.; Zinzani, P. L., Invited Review: Will Consolidation with ASCT Be a Thing of the Past for MCL and PTCL?, «CURRENT HEMATOLOGIC MALIGNANCY REPORTS», 2021, 16, pp. 82 - 88 [articolo]
Broccoli A.; Argnani L.; Morigi A.; Nanni L.; Casadei B.; Pellegrini C.; Stefoni V.; Zinzani P.L., Long-term efficacy and safety of ibrutinib in the treatment of CLL patients: A real life experience, «JOURNAL OF CLINICAL MEDICINE», 2021, 10, Article number: 5845, pp. 5845 - 5845 [articolo]Open Access
Tarantelli, C.; Argnani, L.; Zinzani, P. L.; Bertoni, F., Pi3kδ inhibitors as immunomodulatory agents for the treatment of lymphoma patients, «CANCERS», 2021, 13, pp. 5535 - 5535 [articolo]Open Access
Perrone A.M.; Ferioli M.; Argnani L.; De Terlizzi F.; Pirovano C.; Covarelli P.; Dondi G.; Tesei M.; De Crescenzo E.; Ravegnini G.; Galuppi A.; Morganti A.G.; De Iaco P., Quality of life with vulvar carcinoma treated with palliative electrochemotherapy: The elechtra (electrochemotherapy vulvar cancer) study, «CANCERS», 2021, 13, Article number: 1622, pp. 1622 - 1632 [articolo]Open Access
Coppola P.E.; Broccoli A.; Argnani L.; Casadei B.; Stefoni V.; Bertuzzi C.; Sabattini E.; Zinzani P.L., Rapid but reversible progression and transformation of chronic lymphocytic leukemia after temporary ibrutinib discontinuation due to off-target toxicity: two interesting cases, «LEUKEMIA & LYMPHOMA», 2021, 62, pp. 3540 - 3543 [articolo]
Casadei B, Argnani L, Guadagnuolo S, Pellegrini C, Stefoni V, Broccoli A, Nanni L, Morigi A, Lolli G, Guarino M, Spinardi L, Pierucci E, Fanti S, Bartoletti M, Dicataldo M, Sabattini E, Bonifazi F, Zinzani PL., Real World Evidence of CAR T-Cell Therapies for the Treatment of Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma: A Monocentric Experience., «CANCERS», 2021, 13, pp. 4789 - 4789 [articolo]Open Access
Argnani L.; Zanetti A.; Carrara G.; Silvagni E.; Guerrini G.; Zambon A.; Scire C.A., Rheumatoid Arthritis and Cardiovascular Risk: Retrospective Matched-Cohort Analysis Based on the RECORD Study of the Italian Society for Rheumatology, «FRONTIERS IN MEDICINE», 2021, 8, Article number: 745601, pp. 1 - 7 [articolo]Open Access
Morigi A.; Casadei B.; Argnani L.; Stefoni V.; Sergio E.; Cavo M.; Zinzani P.L., Successful stem cell harvest and autologous transplantation in a patient with cold agglutinin syndrome and aggressive lymphoma, «LEUKEMIA & LYMPHOMA», 2021, 62, pp. 1007 - 1009 [articolo]
Broccoli, A.; Argnani, L.; Nanni, L.; Terragna, C.; Sabattini, E.; Gabrielli, G.; Stefoni, V.; Pellegrini, C.; Casadei, B.; Morigi, A.; Lolli, G.; Carella, M.; Coppola, P. E.; Zinzani, P. L., The treatment of hairy cell leukemia with a focus on long lasting responses to cladribine: A 30-year experience, «AMERICAN JOURNAL OF HEMATOLOGY», 2021, 96, pp. 1204 - 1210 [articolo]Open Access
Casadei B.; Argnani L.; Morigi A.; Lolli G.; Broccoli A.; Pellegrini C.; Nanni L.; Stefoni V.; Coppola P.E.; Carella M.; Cavo M.; Zinzani P.L., Treatment and outcomes of primary mediastinal B cell lymphoma: a three-decade monocentric experience with 151 patients, «ANNALS OF HEMATOLOGY», 2021, 100, pp. 2261 - 2268 [articolo]Open Access
Lolli, Ginevra; Argnani, Lisa; Broccoli, Alessandro; Marangon, Miriam; Pellegrini, Cinzia; Morigi, Alice; Casadei, Beatrice; Nanni, Laura; Stefoni, Vittorio; Carella, Matteo; Cavo, Michele; Zinzani, Pier L, (90) Y-ibritumomab tiuxetan in patients with extra-nodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma) - The Zeno Study, «BRITISH JOURNAL OF HAEMATOLOGY», 2020, 189, pp. 6 - 9 [articolo]
Morigi A.; Argnani L.; Lolli G.; Broccoli A.; Pellegrini C.; Nanni L.; Stefoni V.; Coppola P.E.; Carella M.; Casadei B.; Sabattini E.; Cavo M.; Zinzani P.L., Bendamustine-rituximab regimen in untreated indolent marginal zone lymphoma: experience on 65 patients, «HEMATOLOGICAL ONCOLOGY», 2020, 38, pp. 487 - 492 [articolo]
Stefoni, Vittorio; Marangon, Miriam; Re, Alessandro; Lleshi, Arben; Bonfichi, Maurizio; Pinto, Antonello; Bianchetti, Nicola; Pellegrini, Cinzia; Argnani, Lisa; Zinzani, Pier Luigi, Brentuximab vedotin in the treatment of elderly Hodgkin lymphoma patients at first relapse or with primary refractory disease: a phase 2 study of FIL ONLUS, «HAEMATOLOGICA», 2020, 105, pp. e512 - e514 [articolo]Open Access
Zanetti A.; Scire C.A.; Argnani L.; Carrara G.; Zambon A., Can the adherence to quality of care indicators for early rheumatoid arthritis in clinical practice reduce risk of hospitalisation? Retrospective cohort study based on the Record Linkage of Rheumatic Disease study of the Italian Society for Rheumatology, «BMJ OPEN», 2020, 10, pp. 1 - 9 [articolo]Open Access
Lolli G.; Broccoli A.; Stefoni V.; Argnani L.; Leone O.; Cavo M.; Zinzani P.L., Chronic lymphocytic leukemia focus in the context of a cardiac mass in a pretreated patient: an exceptional incidental finding, «TUMORI», 2020, 106, pp. 29 - 32 [articolo]
